Apyx Medical Announced The Publication Of A Peer-reviewed Article In The Aesthetic Surgery Journal Open Forum, Which Evaluated The Use Of Renuvion For Contracting Subcutaneous Soft Tissue Following Liposuction In Multiple Areas Of The Body
Portfolio Pulse from Benzinga Newsdesk
Apyx Medical announced the publication of a peer-reviewed article in the Aesthetic Surgery Journal Open Forum. The article evaluated the use of Renuvion, a proprietary technology of Apyx Medical, for contracting subcutaneous soft tissue following liposuction in multiple areas of the body.
January 22, 2024 | 12:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The peer-reviewed article on Apyx Medical's Renuvion technology could positively influence the perception of its efficacy in cosmetic surgery, potentially increasing interest and demand for the product.
The publication of a peer-reviewed article often lends credibility to medical technologies, which can lead to increased adoption by practitioners and demand by patients. As Renuvion is a proprietary technology of Apyx Medical, positive study results are likely to have a direct impact on the company's product sales and, consequently, its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100